The Cancer Research Institute invites letters of intent for its clinic and laboratory integration programme grants. These support scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. Grants support preclinical and translational research that can be directly applied to optimising cancer immunotherapy in the clinic.
Candidates must be qualified scientists who hold a faculty appointment as a tenure-track assistant professor, or higher rank, at the time of the award activation. There are no citizenship requirements for candidates, and research may be conducted at medical schools and research centres.
Deadline: 1st December 2024